Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Gastroenterology · Barrett's Esophagus

Can Barrett's Esophagus Be Reversed or Cured Permanently?

At a Glance

Barrett’s esophagus is not guaranteed to be cured forever. If biopsy results show precancerous cell changes, procedures can remove the abnormal lining, but it may return, so acid-reducing medicine and regular endoscopies remain important.

In this answer

3 sections

01

Treatment Depends on Your Biopsy Results

02

Eradicating Dysplastic Barrett’s Esophagus

03

Why “Eradicated” Doesn’t Mean “Cured Forever”

While you cannot “cure” Barrett’s esophagus with a guarantee that it will never return, the abnormal tissue can be reversed and eliminated using specialized procedures [1][2]. However, whether your doctor will recommend actively removing the tissue depends on your specific biopsy results and whether the cells show precancerous changes.

Treatment Depends on Your Biopsy Results

Treatment decisions are based on the degree of cellular change (dysplasia) found during your endoscopy.

  • Non-dysplastic Barrett’s: The cells have changed, but they do not show precancerous features. In this stage, doctors generally do not actively remove the cells because the risks of the procedures outweigh the very low risk of the cells turning into cancer [3][2]. Instead, the focus is on:
    • Acid Suppression: Taking daily medications like proton-pump inhibitors (PPIs) to reduce stomach acid production [4][5]. PPIs help prevent further acid injury, though they do not physically stop reflux from happening or cure the Barrett’s tissue.
    • Routine Surveillance: Endoscopies (using a flexible camera) are typically done every 3 to 5 years to monitor the tissue [4][6]. This interval is not a universal rule; it depends on the length of your Barrett’s segment and your doctor’s assessment [7].
  • Low-Grade Dysplasia: The cells show early precancerous changes. Because this diagnosis can be tricky, it usually requires confirmation by an expert gastrointestinal pathologist. Treatment involves a shared decision between you and your doctor: you may choose close surveillance, or you may opt for active eradication therapy [8][2].
  • High-Grade Dysplasia: The cells show advanced precancerous changes. In this case, doctors strongly recommend active eradication therapy to remove the dangerous tissue before it can progress to cancer [2].

Eradicating Dysplastic Barrett’s Esophagus

When dysplasia is confirmed and treatment is chosen, the goal is complete eradication of intestinal metaplasia—removing all the abnormal tissue so that normal-appearing squamous cells can grow back in their place [2][9]. This process usually requires more than one treatment session. The main techniques include:

  • Endoscopic Mucosal Resection (EMR): If your doctor finds raised, bumpy, or nodular areas of tissue, they will typically use EMR to carefully remove those specific lesions first [2][10]. This removes the highest-risk tissue and allows a pathologist to examine it in a lab.
  • Radiofrequency Ablation (RFA): The most common method for treating flat areas of Barrett’s tissue. A specialized device delivers controlled heat energy to ablate (destroy) the abnormal cells [9][11].
  • Cryotherapy: An established alternative to RFA that uses extreme cold (liquid nitrogen or special gases) to freeze and destroy the cells. It may be used as an initial treatment or if RFA is not fully effective [12][13].

Risks and Recovery: After treatment, it is common to experience temporary chest discomfort, a sore throat, or painful swallowing. More serious, though less common, risks include strictures (narrowing of the esophagus that makes swallowing difficult), bleeding, or perforation (a small tear in the esophagus) [11][14].

  • When to seek urgent care: You should seek immediate medical attention if you experience severe or worsening chest pain, fever, an inability to swallow liquids, vomiting blood, or black stools.

Why “Eradicated” Doesn’t Mean “Cured Forever”

Even when eradication therapy successfully removes all visible Barrett’s tissue, you are not considered permanently cured. The underlying tendency to develop the condition remains, and abnormal cells can recur at or near the treated area over time [1][15]. Furthermore, having well-controlled reflux symptoms does not mean your Barrett’s tissue is gone.

Because of this recurrence risk, strict surveillance continues after successful treatment. This post-treatment schedule is much more frequent than standard monitoring. For example, after treatment for high-grade dysplasia, your doctor may require endoscopies at 3, 6, and 12 months, and then annually [16][17]. Always ask your treating specialist for your specific, written surveillance plan.

Common questions in this guide

Can Barrett's esophagus be cured permanently?
Treatment can remove or destroy all visible Barrett's tissue, but doctors do not guarantee that it is cured forever. Abnormal cells can return near the treated area, so ongoing acid suppression and endoscopic surveillance may still be needed.
Does non-dysplastic Barrett's esophagus need to be removed?
Usually not. When biopsy samples show Barrett's esophagus without precancerous changes, doctors generally recommend acid-reducing treatment and periodic endoscopy rather than tissue-erasing procedures because the procedure risks may outweigh the low progression risk.
How does dysplasia change Barrett's esophagus treatment?
Dysplasia means the cells have precancerous changes, and its grade helps guide treatment. Low-grade dysplasia may be monitored or treated after expert confirmation, while confirmed high-grade dysplasia usually leads to endoscopic eradication therapy.
What procedures can remove Barrett's esophagus tissue?
Endoscopic mucosal resection removes raised or nodular areas so they can be examined. Radiofrequency ablation treats flatter areas with controlled heat, and cryotherapy freezes abnormal cells; more than one session is often needed.
Do proton-pump inhibitors cure Barrett's esophagus?
Proton-pump inhibitors reduce stomach acid and help limit further acid injury, but they do not physically remove Barrett's tissue. Feeling better from reflux treatment does not prove that the abnormal tissue is gone.
How often are endoscopies needed after Barrett's esophagus treatment?
The schedule depends on your biopsy findings and specialist's plan. After treatment for high-grade dysplasia, follow-up may include endoscopies at 3, 6, and 12 months and then every year, but your written schedule may differ.
When should I seek urgent care after Barrett's esophagus treatment?
Seek immediate medical care for severe or worsening chest pain, fever, inability to swallow liquids, vomiting blood, or black stools after treatment. These can signal a serious complication and should not wait for a routine follow-up.

Related questions

What Does LA Grade B Esophagitis Mean on My Endoscopy? How Can You Safely Taper Off PPI Medication for GERD? When Is the Best Time to Take a PPI for GERD? Explained Alginates vs Antacids: Which Helps Nighttime GERD? Are Daily Acid Reflux Pills (PPIs) Safe to Take Long-Term?
Show more
When Do I Need an Endoscopy for Heartburn and GERD? What to Expect During a 96-Hour Bravo pH Test for GERD? LINX vs Nissen for GERD: Which Surgery Is Best for You? Can Weight Loss Cure GERD and Acid Reflux? What to Know What Mimics GERD When PPIs Do Not Work? Causes and Testing What Foods Trigger GERD? Must I Avoid Them Completely? Can GERD Cause Morning Hoarseness and Throat Irritation? How Does Stress Affect GERD and Heartburn Symptoms? Why Is Esophageal Manometry Recommended Before GERD Surgery? Does Gastric Sleeve Cause or Worsen GERD Symptoms? Which Specialists Treat Severe or Refractory GERD?

Get notified when new evidence is published on gastroesophageal reflux disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    Recurrent intestinal metaplasia at the gastroesophageal junction following endoscopic eradication of dysplastic Barrett's esophagus may not be benign.

    Cameron GR, Desmond PV, Jayasekera CS, et al.

    Endoscopy international open 2016; (4(8)):E849-58 doi:10.1055/s-0042-109608.

    PMID: 27540572
  2. 2

    AGA Clinical Practice Guideline on Endoscopic Eradication Therapy of Barrett's Esophagus and Related Neoplasia.

    Rubenstein JH, Sawas T, Wani S, et al.

    Gastroenterology 2024; (166(6)):1020-1055 doi:10.1053/j.gastro.2024.03.019.

    PMID: 38763697
  3. 3

    Management of nondysplastic Barrett's esophagus: When to survey? When to ablate?

    Puthenpura MM, Sanaka KO, Qin Y, Thota PN

    Therapeutic advances in chronic disease 2022; (13()):20406223221086760 doi:10.1177/20406223221086760.

    PMID: 35432847
  4. 4

    AGA Clinical Practice Update on New Technology and Innovation for Surveillance and Screening in Barrett's Esophagus: Expert Review.

    Muthusamy VR, Wani S, Gyawali CP, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2022; (20(12)):2696-2706.e1 doi:10.1016/j.cgh.2022.06.003.

    PMID: 35788412
  5. 5

    Antireflux Surgery for Barrett's Esophagus: Where Do We Stand in Preventing Esophageal Adenocarcinoma?

    Kollmann D, Etyemez C, Asari R, et al.

    Annals of the New York Academy of Sciences 2026; (1556(1)):e70196 doi:10.1111/nyas.70196.

    PMID: 41649862
  6. 6

    ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus.

    Shaheen NJ, Falk GW, Iyer PG, et al.

    The American journal of gastroenterology 2016; (111(1)):30-50; quiz 51 doi:10.1038/ajg.2015.322.

    PMID: 26526079
  7. 7

    Significantly lower annual rates of neoplastic progression in short- compared to long-segment non-dysplastic Barrett's esophagus: a systematic review and meta-analysis.

    Chandrasekar VT, Hamade N, Desai M, et al.

    Endoscopy 2019; (51(7)):665-672 doi:10.1055/a-0869-7960.

    PMID: 30939618
  8. 8

    Efficacy and Safety of Radiofrequency Ablation vs. Endoscopic Surveillance for Barrett's Esophagus With Low-Grade Dysplasia: Meta-Analysis of Randomized Controlled Trials.

    Wang Y, Ma B, Yang S, et al.

    Frontiers in oncology 2022; (12()):801940 doi:10.3389/fonc.2022.801940.

    PMID: 35296005
  9. 9

    Endoscopic Therapy in Barrett's Esophagus.

    Gauci JL, Pouw RE

    Visceral medicine 2026; doi:10.1159/000550939.

    PMID: 42027355
  10. 10

    State-of-the-art management of dysplastic Barrett's esophagus.

    Vantanasiri K, Iyer PG

    Gastroenterology report 2022; (10()):goac068 doi:10.1093/gastro/goac068.

    PMID: 36381221
  11. 11

    Comparing outcome of radiofrequency ablation in Barrett's with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry.

    Haidry RJ, Lipman G, Banks MR, et al.

    Endoscopy 2015; (47(11)):980-7 doi:10.1055/s-0034-1392414.

    PMID: 26126159
  12. 12

    Cryotherapy versus radiofrequency ablation in the treatment of dysplastic Barrett's esophagus with or without early esophageal neoplasia: a systematic review and meta-analysis.

    Gomes ILC, de Moura DTH, Ribeiro IB, et al.

    Clinical endoscopy 2024; (57(2)):181-190 doi:10.5946/ce.2023.065.

    PMID: 38229440
  13. 13

    Salvage cryotherapy in patients undergoing endoscopic eradication therapy for complicated Barrett's esophagus.

    Spiceland CM, Elmunzer BJ, Paros S, et al.

    Endoscopy international open 2019; (7(7)):E904-E911 doi:10.1055/a-0902-4587.

    PMID: 31281876
  14. 14

    Adverse Events After Radiofrequency Ablation in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis.

    Qumseya BJ, Wani S, Desai M, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2016; (14(8)):1086-1095.e6.

    PMID: 27068041
  15. 15

    Long-term outcomes after endoscopic eradication therapy for dysplastic and T1a adenocarcinoma-related Barrett's esophagus: higher rate of late dysplastic recurrence with radiofrequency ablation monotherapy.

    He T, Sundararajan V, Clark NJ, et al.

    Gastrointestinal endoscopy 2025; (102(2)):184-193.e2 doi:10.1016/j.gie.2025.01.026.

    PMID: 39870246
  16. 16

    Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline.

    Shaheen NJ, Falk GW, Iyer PG, et al.

    The American journal of gastroenterology 2022; (117(4)):559-587 doi:10.14309/ajg.0000000000001680.

    PMID: 35354777
  17. 17

    Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.

    Wani S, Rubenstein JH, Vieth M, Bergman J

    Gastroenterology 2016; (151(5)):822-835 doi:10.1053/j.gastro.2016.09.040.

    PMID: 27702561

This information about reversal and eradication of Barrett's esophagus is for educational purposes only and does not constitute medical advice. Your gastroenterologist should interpret your biopsy results and recommend treatment and surveillance for your situation.